Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,774 total articles

Fort Technology Signs Agreements for the Acquisition of Logia USA -  Fuel Integrity Solutions for Data Centers Company

Fort Technology Signs Agreements for the Acquisition of Logia USA - Fuel Integrity Solutions for Data Centers Company

Fort Technology Inc. announced entering into an agreement to acquire 50.1% of Logia USA, a company specializing in automated fuel integrity solutions tailored for data centers and mission-critical facilities. The acquisition includes a licensing agreement with Logia Israel for exclusive US rights to develop, manufacture, and commercialize these sys…

Callan JMB, Bia Power Systems and Alabama State University Announce $60 Million Advanced Electrical Manufacturing Venture in Brewton, Alabama

Callan JMB, Bia Power Systems and Alabama State University Announce $60 Million Advanced Electrical Manufacturing Venture in Brewton, Alabama

Callan JMB Inc., Bia Power Systems LLC, and Alabama State University announced a joint venture to establish an advanced electrical equipment manufacturing and assembly facility in Brewton, Alabama. This $60 million investment aims to expand domestic production of transformers and power-distribution equipment to meet growing demand in utilities, dat…

Big Sky Industrial Inc. Reports Second Quarter 2026 Results and Highlights Phase 1 Construction Progress at Big Sky Carbon Hub

Big Sky Industrial Inc. Reports Second Quarter 2026 Results and Highlights Phase 1 Construction Progress at Big Sky Carbon Hub

Big Sky Industrial Inc. reported Q2 2026 financial results highlighting ongoing construction of its Phase 1 helium processing facility at the Big Sky Carbon Hub with targeted first revenue in Q1 2027. The company executed a five-year, 100% take-or-pay helium offtake agreement at a fixed price of $285/Mcf, amended its senior secured credit facility …

Circle8 Ranked #1 in 2025 Dutch Public-Sector Broker/MSP Contract Awards, With Approximately US$2.39 Billion in Awarded Framework Value

Circle8 Ranked #1 in 2025 Dutch Public-Sector Broker/MSP Contract Awards, With Approximately US$2.39 Billion in Awarded Framework Value

Circle8 Group, Inc. has been ranked as the number one Broker/MSP provider in Dutch public-sector contract awards for 2025, capturing approximately €2.07 billion (~US$2.39 billion) across six framework agreements. This leading position underscores its strong presence in the public-sector workforce market in the Netherlands and provides significant o…

YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

YD Bio Limited announced the launch of two physician-partnered chrono-nutrition nutraceutical formulations in Taiwan, developed collaboratively with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute. This initiative marks the company's first step in building a repeatable physician-partnership ecosystem aimed at meeti…

Abundia Global Impact Group Provides Business Update Highlighting Continued Execution of Commercialization Strategy

Abundia Global Impact Group Provides Business Update Highlighting Continued Execution of Commercialization Strategy

Abundia Global Impact Group, Inc. announced significant progress in its commercialization strategy during Q2 2026, including the acquisition and integration of RPD Technologies, expansion of its Cedar Port facility, and securing strategic partnerships such as with Topsoe and Burns & McDonnell. The company increased revenue to $2 million for the qua…

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Mereo BioPharma has partnered with Sentynl Therapeutics to grant Sentynl exclusive US commercialization and global manufacturing rights for alvelestat, an investigational oral treatment for Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD). The agreement includes upfront payments, milestone potential up to $435 million, and royalties…

CN Reports a Record 2025-26 Crop Year

CN Reports a Record 2025-26 Crop Year

CN announced a record movement of over 33.8 million metric tonnes of grain from Western Canada during the 2025-26 crop year, surpassing the previous year's record. This growth was driven by strong customer demand and operational efficiency. CN also released its 2026-27 Grain Plan aimed at further supporting the grain supply chain in the upcoming ha…

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company listed on Nasdaq, announced receipt of an additional A$5.1 million R&D tax incentive refund from the Australian Government. This completes over A$11.2 million received in 2026 as non-dilutive capital, enhancing the company's cash position and debt-free balance sheet to support adv…

Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders

Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders

Anavex Life Sciences Corp. filed its definitive proxy materials for the upcoming 2026 Annual Meeting, urging stockholders to vote for its six highly qualified, independent director nominees. The company highlights recent leadership changes to stabilize operations and advance its CNS-focused drug development programs, particularly the oral blarcames…

Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth

Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth

Bicara Therapeutics reported Q2 2026 financials and strategic leadership updates. Ryan Cohlhepp will become CEO in January 2027, succeeding Claire Mazumdar who will transition to Vice Chair and Strategic Advisor. The company is progressing enrollment for the pivotal FORTIFI-HN01 trial of its lead drug, ficerafusp alfa, targeting HPV-negative head a…

Stardust Power Appoints Ray Rivers to Board of Directors

Stardust Power Appoints Ray Rivers to Board of Directors

Stardust Power Inc., a U.S.-based developer of battery-grade lithium carbonate refineries, appointed V. Ray Rivers to its Board of Directors. Rivers brings over 30 years of capital markets and financial services expertise, taking roles on the Audit and Compensation Committees. This strategic appointment aims to deepen the Board's financial expertis…

Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma

Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma

Eikon Therapeutics announced the selection of a 0.60 mg/m² dose for EIK1001 in the adaptive Phase 2/3 TeLuRide-006 trial for advanced melanoma, following a recommendation from an independent Data Monitoring Committee. EIK1001 is an investigational dual TLR7/8 agonist designed to stimulate innate and adaptive immunity, potentially enhancing response…

ZenaTech’s ZenaDrone Begins In-House PCB Flight Testing, Advancing Vertical Integration Strategy Toward NDAA-Compliant Blue UAS Certification and Expanded Defense Opportunities

ZenaTech’s ZenaDrone Begins In-House PCB Flight Testing, Advancing Vertical Integration Strategy Toward NDAA-Compliant Blue UAS Certification and Expanded Defense Opportunities

ZenaTech, Inc., a Nasdaq-listed AI drone technology company, announced that its subsidiary ZenaDrone has begun flight testing custom-designed PCBs made in-house at its Taiwan subsidiary and integrated at its UAE facility. This advances their vertical integration strategy aimed at achieving NDAA-compliant Blue UAS certification, facilitating access …